1. World Health Organization. (2016). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations.
2, Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141: 166–172
3. Kassanjee, R., Pilcher, C.D., Keating, S., Facente, S.N, McKinney, E., Price, M.A., Welte, A. (2014). Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS (London, England), 28(16), 2439.
4. Granade, T. C., Nguyen, S., Kuehl, D. S., & Parekh, B. S. (2013). Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device. AIDS research and human retroviruses, 29(1), 61-67.
5. Technical Update on HIV Incidence Assays for Surveillance and Monitoring Purposes. UNAIDS/WHO, 2015.
6. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998, 280:42-48
7. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and -estimating incidence. AIDS Res Hum Retroviruses 2002, 18:295-307.
8. Young CL, Hu DJ, Byers R, et al. Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B’ or E infection in Thailand. AIDS Res Hum Retroviruse 2003, 19:481-486.
9. Karita E, Price M, Hunter E, Chomba E, Allen S, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007, 21:403-408.
10. Laeyendecker O, Oliver A, Astemborski J, Owen SM, Kirk G, et al. Improved precision of crosssectional HIV incidence testing using a multi-assay algorithm that includes BED and an avidity assay with modified assay cut-offs. Conference on Retroviruses and Opportunistic Infections. San Francisco. 2010, #935.
11. Wei X, Liu X, Dobbs T, Kuehl et al. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res Hum Retroviruses 2010, 26:1-11.
12. Sedia Bioscienses Corporation. (2016). SediaTM HIV-1 Lag-Avidity EIA: Single Well Avidity Enzyme Immunoassay for Detection of Recent HIV-1 Infection Using Serum of Plasma Only. Portland, Oregon, United States
13. Sedia Bioscienses Corporation. (2017). Asanté HIV Rapid Recency Assay: Rapid in vitro immunoassay for determining Recency of Human Immunodeficiency Virus (HIV-1) infections.
Portland, Oregon, United States